Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia

Pancreatic Cancer

Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969

Circulating mutant DNA to assess tumor dynamics

Diehl, F., Schmidt, K., Choti, M. A., Romans, K. E., Goodman, S. N., Li, M., Thornton, K. A., Agrawal, N., Sokoll, L. J., Szabo, S., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,746

Pancreatic cancer

Vincent, A., Herman, J. M., Schulick, R., Hruban, R. H., & Goggins, M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62307-0 · Cited by 2,678

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471

Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions

Hruban, R. H., Adsay, N. V., Albores–Saavedra, J., Compton, C., Garrett, E. S., Goodman, S. N., Kern, S. E., Klimstra, D. S., Klöppel, G., Longnecker, D. S., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200105000-00003 · Cited by 1,126

Senescence-messaging secretome: SMS-ing cellular stress

Kuilman, T., & Peeper, D. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2560 · Cited by 909

Progression model for pancreatic cancer.

Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 872

Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development

Wu, J., Matthaei, H., Maitra, A., Molin, M. D., Wood, L., Eshleman, J., Goggins, M., Canto, M., Schulick, R., Edil, B., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002543 · Cited by 786

When cells get stressed: an integrative view of cellular senescence

Ben-Porath, I., & Weinberg, R. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420663 · Cited by 404

Team work and cytopathology molecular diagnosis of solid pancreatic lesions

Fabbri, C., Gibiino, G., Fornelli, A., Cennamo, V., Grifoni, D., Visani, M., Acquaviva, G., Fassan, M., Fiorino, S., Giovanelli, S., et al. (2017) · Digestive Endoscopy · doi:10.1111/den.12845 · Cited by 14

Role of genetic testing in hepatic, pancreatic, and biliary cancers

Hewitt, D. B., Aziz, H., Brown, Z. J., & Pawlik, T. M. (2022) · Surgical Oncology · doi:10.1016/j.suronc.2022.101844 · Cited by 14

A Practical Approach to Interpreting Circulating Tumor DNA in the Management of Gastrointestinal Cancers

Allan, Z., Liu, D. S., Lee, M., Tie, J., & Clemons, N. J. (2024) · Clinical Chemistry · doi:10.1093/clinchem/hvad188 · Cited by 14

Neue Einblicke in die Entstehung des Pankreaskarzinoms

Esposito, I., Konukiewitz, B., Schlitter, A. M., & Klöppel, G. (2012) · Der Pathologe · doi:10.1007/s00292-012-1673-x · Cited by 14

mAb Das-1 identifies pancreatic ductal adenocarcinoma and high-grade pancreatic intraepithelial neoplasia with high accuracy

Das, K. K., Brown, J. W., del-Castillo, C. F., Huynh, T. G., Mills, J. C., Matsuda, Y., Das, K. M., & Mino-Kenudson, M. A. (2021) · Human Pathology · doi:10.1016/j.humpath.2021.01.003 · Cited by 12

Anoikis-Related Gene Signature for Prognostication of Pancreatic Adenocarcinoma: A Multi-Omics Exploration and Verification Study

Zhang, J., Li, X., Lu, Y., Wang, G., & Ma, Y. (2023) · Cancers · doi:10.3390/cancers15123146 · Cited by 14

Computer-aided assessment of the extra-cellular matrix during pancreatic carcinogenesis: a pilot study

Grizzi, F., Fiorino, S., Qehajaj, D., Fornelli, A., Russo, C., de Biase, D., Masetti, M., Mastrangelo, L., Zanello, M., Lombardi, R., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1817-3 · Cited by 14

Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma

Liu, P., Jacques, J., & Hwang, C. (2024) · Epigenomes · doi:10.3390/epigenomes8040041 · Cited by 13

Pancreatic cancer

Roth, S., Apte, M. V., Balachandran, V. P., Biffi, G., Conroy, T., Cukierman, E., Dotan, E., Esposito, I., Grünwald, B. T., Klauß, M., et al. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-026-00699-6 · Cited by 19

Stem/progenitor cells in normal physiology and disease of the pancreas

Fallas, M. E. A., Pedraza‐Arévalo, S., Cujba, A.-M., Manea, T., Lambert, C., Morrugares, R., & Sancho, R. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111459 · Cited by 16

Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer

Guo, D., Ye, L., Wu, W., Yu, X., & Jin, K. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023045 · Cited by 13

Personalized treatment in localized pancreatic cancer

Neoptolemos, J. P., Hu, K., Bailey, P. J., Springfeld, C., Cai, B., Miao, Y., Michalski, C. W., Carvalho, C. T., Hackert, T., & Büchler, M. W. (2023) · European surgery. Supplement/European surgery · doi:10.1007/s10353-023-00814-x · Cited by 13

Genetic Signature of Human Pancreatic Cancer and Personalized Targeting

Reshkin, S. J., Cardone, R. A., & Koltai, T. (2024) · Cells · doi:10.3390/cells13070602 · Cited by 14

Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients

Kim, M., Kim, M., Kim, S. J., An, S., Park, H., Park, H., Lee, J. H., Song, K.-B., Hwang, D. W., Chang, S., et al. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0416-8 · Cited by 14

Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts

Ruess, D. A., Görgülü, K., Wörmann, S. M., & Algül, H. (2017) · Drugs & Aging · doi:10.1007/s40266-017-0453-y · Cited by 15

Signaling levels mold the RAS mutation tropism of urethane

Li, S., & Counter, C. M. (2021) · eLife · doi:10.7554/elife.67172 · Cited by 13

GLP-1 Receptor Agonist Effects on Normal and Neoplastic Pancreata

Goggins, M. (2012) · Diabetes · doi:10.2337/db12-0233 · Cited by 13

Challenges in genomic analysis of model systems and primary tumors of pancreatic ductal adenocarcinoma

Hyun, S., & Park, D. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.08.064 · Cited by 11

Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression

Chowdhury, N. N., Yang, Y., Dutta, A., Luo, M., Wei, Z., Abrahams, S. R., Revenko, A. S., Shah, F., Miles, L. A., Parmer, R. J., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13552 · Cited by 12

The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promising circulating biomarkers

Mottini, C., Auciello, F. R., Manni, I., Pilarsky, C. P., Caputo, D. D., Caracciolo, G., Rossetta, A., Gennaro, E. D., Budillon, A., Blandino, G., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03117-5 · Cited by 12

Identification and analysis of pancreatic intraepithelial neoplasia: opportunities and challenges

Pian, L.-L., Song, M.-H., Wang, T., Qi, L., Peng, T.-L., & Xie, K.-P. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1401829 · Cited by 15

Genetics of pancreatic cancer and implications for therapy

Bhosale, P., Cox, V. L., Faria, S. C., Javadi, S., Viswanathan, C., Koay, E. J., & Tamm, E. P. (2017) · Abdominal Radiology · doi:10.1007/s00261-017-1394-y · Cited by 12

Transportome Malfunctions and the Hallmarks of Pancreatic Cancer

Ling, Q., & Kalthoff, H. (2020) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2020_20 · Cited by 12

Relevance of gene mutations and methylation to the growth of pancreatic intraductal papillary mucinous neoplasms based on pyrosequencing

Asano, G., Miyabe, K., Kato, H., Yoshida, M., Sawada, T., Okamoto, Y., Sahashi, H., Atsuta, N., Kachi, K., Kato, A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-04335-z · Cited by 13

The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells

Palanivel, C., Chaudhary, N., Seshacharyulu, P., Cox, J. L., Yan, Y., Batra, S. K., & Ouellette, M. M. (2022) · Neoplasia · doi:10.1016/j.neo.2022.01.002 · Cited by 12

Kras Gene Analysis Using Liquid-Based Cytology Specimens Predicts Therapeutic Responses and Prognosis in Patients with Pancreatic Cancer

Itonaga, M., Ashida, R., Murata, S., Yamashita, Y., Hatamaru, K., Tamura, T., Kawaji, Y., Kayama, Y., Emori, T., Kawai, M., et al. (2022) · Cancers · doi:10.3390/cancers14030551 · Cited by 12

Multiplex Digital PCR Assay to Detect Multiple KRAS and GNAS Mutations Associated with Pancreatic Carcinogenesis from Minimal Specimen Amounts

Maeda, C., Ono, Y., Hayashi, A., Takahashi, K., Taniue, K., Kakisaka, R., Mori, M., Ishii, T. M., Sato, H., Okada, T., et al. (2023) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2023.02.007 · Cited by 12

Advanced pancreatic cancer with KRAS wild-type and EGFR-sensitive mutation respond favorably to furmonertinib: A case report

Ma, X., Liu, X., Ou, K., Zhang, M., Gao, L., & Yang, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1151178 · Cited by 12

High-Content, Full Genome siRNA Screen for Regulators of Oncogenic HRAS -Driven Macropinocytosis

Fennell, M., Commisso, C., Ramírez, C., Garippa, R. J., & Bar‐Sagi, D. (2015) · Assay and Drug Development Technologies · doi:10.1089/adt.2015.660 · Cited by 12

Mutations in the p16 gene in DMBA-induced pancreatic intraepithelial neoplasia and pancreatic cancer in rats

Zhu, Z., Liu, T., Han, F., Zhan, S., & Wang, C. (2015) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(15)60331-9 · Cited by 12

Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury

Fendrich, V., Jendryschek, F. S., Beeck, S., Albers, M. B., Lauth, M., Esni, F., Heeger, K., Dengler, J., Slater, E. P., Holler, J. P. N., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0100-4 · Cited by 12

Molecular Approaches Using Body Fluid for the Early Detection of Pancreatic Cancer

Satoh, K. (2021) · Diagnostics · doi:10.3390/diagnostics11020375 · Cited by 12

Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transition

Reyes, J., Priore, I. S. D., Chaikovsky, A. C., Pasnuri, N., Elhossiny, A. M., Park, J., Weiler, P., Krause, T., Moorman, A. R., Snopkowski, C., et al. (2026) · Cell · doi:10.1016/j.cell.2026.03.032 · Cited by 12

Emerging applications of cancer bacteriotherapy towards treatment of pancreatic cancer

Henderson, E. A., Łukomski, S., & Boone, B. A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1217095 · Cited by 11

Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such as serpin E1 and CCL5

Gong, J., Li, X., Feng, Z., Lou, J., Pu, K., Sun, Y., Hu, S., Zhou, Y., Song, T., Shangguan, M., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01346-4 · Cited by 11

Personalized Management of Pancreatic Ductal Adenocarcinoma Patients through Computational Modeling

Yamamoto, K. N., Yachida, S., Nakamura, A., Niida, A., Oshima, M., De, S., Rosati, L. M., Herman, J. M., Iacobuzio–Donahue, C. A., & Haeno, H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1208 · Cited by 11

Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR)

Velasco, R. M., Sánchez, P. J., García, A. G., Martínez-Illescas, R. B., Senovilla, Á. P., Yagüe, M. L., Trento, A., García-Martín, R., Navarro, D., Sáinz, B., et al. (2022) · Cancers · doi:10.3390/cancers14061518 · Cited by 11

Lipid raft protein flotillin‐1 is important for the interaction between SOS1 and H‐Ras / K‐Ras , leading to Ras activation

Jin, H., Koh, M., Lim, H., Yong, H., Kim, E., Kim, S. Y., Kim, K., Jung, J., Ryu, W., Choi, K., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34443 · Cited by 12

Multiple KRAS mutations in the non‐mucinous epithelial lining in the majority of mucinous cystic neoplasms of the pancreas

An, S., Kim, M., Kim, S. J., Sung, Y.-N., Kim, Y. W., Song, K. B., Hwang, D. W., Kim, S. C., Hruban, R. H., & Hong, S. (2019) · Histopathology · doi:10.1111/his.13897 · Cited by 11

Carboxypeptidase E-∆N Promotes Proliferation and Invasion of Pancreatic Cancer Cells via Upregulation of CXCR2 Gene Expression

Hareendran, S., Yang, X.-Y., Lou, H., Xiao, L., & Loh, Y. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225725 · Cited by 11

Epithelial cell transforming 2 is regulated by Yes-associated protein 1 and mediates pancreatic cancer progression and metastasis

Li, C., Peng, Z., Wang, Y., Lam, G., Nissen, N. N., Tang, J., Yuan, X., Lewis, M. S., Greene, M. I., Pandol, S. J., et al. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00185.2020 · Cited by 11

Discrimination between Pancreatic Cancer, Pancreatitis and Healthy Controls Using Urinary Polyamine Panel

Nissinen, S. I., VENÄLÄINEN, M. K., Kumpulainen, P. S., Roine, A., Häkkinen, M. R., Vepsäläinen, J., Oksala, N., & Rantanen, T. K. (2021) · Cancer Control · doi:10.1177/10732748211039762 · Cited by 11

New Insights Into the Cell Lineage of Pancreatic Ductal Adenocarcinoma: Evidence for Tumor Stem Cells in Premalignant Lesions?

Kopp, J. L., & Sander, M. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.11.023 · Cited by 11

Longitudinal Analysis of Human Pancreatic Adenocarcinoma Development Reveals Transient Gene Expression Signatures

Kim, J., Ekstrom, T. J., Yang, W., Donahue, G., Grygoryev, D., Ngo, T. T. M., Muschler, J. L., Morgan, T. K., & Zaret, K. S. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0483 · Cited by 10

Investigation of early neoplastic transformation and premalignant biology using genetically engineered organoid models

Zhao, H., Collet, C., Peng, D., Sinha, U. K., & Lin, D. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.09.026 · Cited by 9

Interplay between MAP kinases and tumor microenvironment: Opportunity for immunotherapy in pancreatic cancer

Kumar, S., Singh, S. K., Srivastava, P., Suresh, S., Rana, B., & Rana, A. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2023.02.003 · Cited by 10

Coxsackievirus and adenovirus receptor expression facilitates enteroviral infections to drive the development of pancreatic cancer

Bastea, L. I., Liu, X., Martinez, A. K. F., Pandey, V., Döppler, H. R., Edenfield, B. H., Krishna, M., Zhang, L., Thompson, E. A., Grandgenett, P. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-55043-x · Cited by 13

Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives

Hashimoto, A., & Hashimoto, S. (2024) · Cancers · doi:10.3390/cancers16234094 · Cited by 11

Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer: A Prospective Cohort Study

Leiting, J. L., Alva‐Ruiz, R., Yonkus, J. A., Abdelrahman, A. M., Lynch, I. T., Carlson, D. M., Carr, R. M., Salomão, D. R., McWilliams, R. R., Starlinger, P. P., et al. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-17036-y · Cited by 10

Use of the Malaria Protein VAR2CSA for the Detection of Small Extracellular Vesicles to Diagnose Adenocarcinoma

Zhao, Y., Wen, C., Wang, Q., Yue, Q., Tondi, S., Reina, C., Šabanović, B., Chang, C. Y., Lai, C., Wang, H., et al. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70067 · Cited by 10

PHF13 epigenetically activates TGFβ driven epithelial to mesenchymal transition

Sun, Y., Li, D., Liu, H., Huang, Y., Meng, F., Tang, J., Li, Z., & Xie, W. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04940-4 · Cited by 10

Molecular analysis of mucinous nonneoplastic cyst of the pancreas

Zhu, B. Y., Finkelstein, S. D., Feng, G., Keswani, R. N., & Lin, X. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.05.009 · Cited by 10

Aberrant (pro)renin receptor expression induces genomic instability in pancreatic ductal adenocarcinoma through upregulation of SMARCA5/SNF2H

Shibayama, Y., Takahashi, K., Yamaguchi, H., Yasuda, J., Yamazaki, D., Rahman, A., Fujimori, T., Fujisawa, Y., Takai, S., Furukawa, T., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01434-x · Cited by 10

Clinical and genetic characteristics in pancreatic cancer from Chinese patients revealed by whole exome sequencing

He, Y., Huang, W. J., Tang, Y., Li, Y., Peng, X., Li, J., Wu, J. Y., You, N., Li, L., Liu, C., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1167144 · Cited by 10

Pancreatic Cancer Genomes: Toward Molecular Subtyping and Novel Approaches to Diagnosis and Therapy

Wood, L. D. (2013) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-013-0043-6 · Cited by 10

Recent Anti-KRASG12D Therapies: A “Possible Impossibility” for Pancreatic Ductal Adenocarcinoma

Sobhani, N., Pittacolo, M., D’Angelo, A., & Marchegiani, G. (2025) · Cancers · doi:10.3390/cancers17040704 · Cited by 12

Fibroblast STAT3 Activation Drives Organ-Specific Premetastatic Niche Formation

Opsahl, E. L. L., Espinoza, C. E., Olivei, A. C., Okoye, J. O., Watkoske, H. R., Hoffman, M. T., Avritt, F. R., Elhossiny, A. M., Bischoff, A. C., Donahue, K. L., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-3472 · Cited by 9

Aberrant transcription factors in the cancers of the pancreas

Uddin, M. H., Al-Hallak, M. N., Philip, P. A., Chen, H., El‐Rayes, B. F., & Azmi, A. S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.08.011 · Cited by 9

Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer

Marin, A. M., Sanchuki, H. B. S., Namur, G. N., Uno, M., Zanette, D. L., & Aoki, M. N. (2023) · Biomedicines · doi:10.3390/biomedicines11041069 · Cited by 9

Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasm of the Pancreas

Kuvendjiska, J., Müller, F., Bronsert, P., Timme‐Bronsert, S., Fichtner‐Feigl, S., & Kulemann, B. (2023) · Life · doi:10.3390/life13071570 · Cited by 10

Tetrandrine synergizes with MAPK inhibitors in treating KRAS-mutant pancreatic ductal adenocarcinoma via collaboratively modulating the TRAIL-death receptor axis

Tang, S., Duan, Y., Yuan, T., Hu, Y., Yuan, L., Shen, N., Fu, Y., Pu, C., Wang, X., Xu, J. Q., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106955 · Cited by 9

Exploring the Therapeutic Potential of Focal Adhesion Kinase Inhibition in Overcoming Chemoresistance in Pancreatic Ductal Adenocarcinoma

Scianò, F., Terrana, F., Pecoraro, C., Parrino, B., Cascioferro, S., Diana, P., Giovannetti, E., & Carbone, D. (2024) · Future Medicinal Chemistry · doi:10.4155/fmc-2023-0234 · Cited by 9

Concurrent inhibition of pBADS99 synergistically improves MEK inhibitor efficacy in KRASG12D-mutant pancreatic ductal adenocarcinoma

Tan, Y. Q., Sun, B., Zhang, X., Zhang, S., Guo, H., Basappa, B., Zhu, T., Sethi, G., Lobie, P. E., & Pandey, V. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06551-7 · Cited by 10

Intratumor Heterogeneity of KRAS Mutation Status in Pancreatic Ductal Adenocarcinoma Is Associated With Smaller Lesions

Nagawkar, S. S., Abu-Funni, S., Simon, E., Bick, T., Prinz, E., Sabo, E., Ben‐Izhak, O., & Hershkovitz, D. (2015) · Pancreas · doi:10.1097/mpa.0000000000000562 · Cited by 9

Scientific rationale for integrative and personalised strategies for pancreatic ductal adenocarcinoma management

Korhan, P., Verkerk, R. M., & Critchley, W. R. (2017) · Integrative Molecular Medicine · doi:10.15761/imm.1000310 · Cited by 8

Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas

Fujiwara, S., Saiki, Y., Ishizawa, K., Fukushige, S., Yamanaka, M., Sato, M., Ishida, M., Motoi, F., Unno, M., & Horii, A. (2019) · Cancer Medicine · doi:10.1002/cam4.2016 · Cited by 9

Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice

Tsesmelis, M., Tiwary, K., Steiger, K., Sperb, N., Gerstenlauer, M., Manfras, U., Maier, H. J., Hermann, P. C., Chan, L. K., & Wirth, T. (2021) · Cancers · doi:10.3390/cancers13184541 · Cited by 9

The Functional Role of LncRNA UCA1 in Pancreatic Cancer: a mini-review

Sun, C.-C., Li, L., Jiang, Z., Liu, Z., Wang, L., & Wang, H. (2023) · Journal of Cancer · doi:10.7150/jca.79171 · Cited by 9

Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression

Durante, S., Vecchiarelli, S., Astolfi, A., Grassi, E., Casadei, R., Santini, D., Panzacchi, R., Ricci, C., Serravalle, S., Tarantino, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11501 · Cited by 9

Treatment of Pancreatic Cancer by Aptamer Conjugated C/EBPα-saRNA

Yoon, S., & Rossi, J. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4310-9_12 · Cited by 9

The potential application of stroma modulation in targeting tumor cells: Focus on pancreatic cancer and breast cancer models

Roscigno, G., Jacobs, S., Toledo, B., Borea, R., Russo, G., Pepe, F., Serrano, M. J., Calabrò, V., Troncone, G., Giovannoni, R., et al. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.05.003 · Cited by 9

PET–Computed Tomography and Precision Medicine in Pancreatic Adenocarcinoma and Pancreatic Neuroendocrine Tumors

Pinho, D. F., & Subramaniam, R. M. (2017) · PET Clinics · doi:10.1016/j.cpet.2017.05.003 · Cited by 8

Power-law growth models explain incidences and sizes of pancreatic cancer precursor lesions and confirm spatial genomic findings

Kiemen, A. L., Wu, P.-H., Braxton, A. M., Cornish, T. C., Hruban, R. H., Wood, L. D., Wirtz, D., & Zwicker, D. (2024) · Science Advances · doi:10.1126/sciadv.ado5103 · Cited by 8

Elevated expression of the V‐ATPase D2 subunit triggers increased energy metabolite levels in KrasG12D‐driven cancer cells

Yang, J., Guo, F., Yuan, L., Lv, G., Gong, J., & Chen, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28448 · Cited by 8

Pancreatic Cancer

Herman, J. M., Crane, C. H., Iacobuzio–Donahue, C. A., & Abrams, R. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24098-7.00048-4 · Cited by 8

Intraduktale Pankreasneoplasien

Esposito, I., Häberle, L., Yavas, A., Kraft, A., & Gaida, M. M. (2021) · Der Pathologe · doi:10.1007/s00292-021-00966-1 · Cited by 9

The genetic classification of pancreatic neoplasia

Matthaei, H., Semaan, A., & Hruban, R. H. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1037-4 · Cited by 10

Baiting for Cancer: Using the Zebrafish as a Model in Liver and Pancreatic Cancer

Hwang, K. L., & Goessling, W. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-30654-4_17 · Cited by 8

Proteasome activity is required for the initiation of precancerous pancreatic lesions

Furuyama, T., Tanaka, S., Shimada, S., Akiyama, Y., Matsumura, S., Mitsunori, Y., Aihara, A., Ban, D., Ochiai, T., Kudo, A., et al. (2016) · Scientific Reports · doi:10.1038/srep27044 · Cited by 8

The Mouse Model of Pancreatic Cancer Atlas (MMPCA) for classification of pancreatic cancer lesions: A large histological investigation of the Ptf1aCre/+;LSL-KrasG12D/+ transgenic mouse model of pancreatic cancer

Veite-Schmahl, M. J., Rivers, A. C., Regan, D. P., & Kennedy, M. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187552 · Cited by 8

Intrapancreatic recurrence of intraductal tubulopapillary neoplasm (ITPN) 16 years after the initial surgery for noninvasive ITPN: a case report

Saeki, K., Miyasaka, Y., Ohishi, Y., Yamamoto, T., Matsuda, R., Mochidome, N., Mori, Y., Nakata, K., Ohtsuka, T., Ishigami, K., et al. (2018) · Surgical Case Reports · doi:10.1186/s40792-018-0497-1 · Cited by 8

Pancreatic cancer driver mutations are targetable through distant alternative RNA splicing dependencies

Kawalerski, R. R., Leach, S. D., & Escobar‐Hoyos, L. F. (2021) · Oncotarget · doi:10.18632/oncotarget.27901 · Cited by 8

Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice

Ikuta, K., Fukuda, A., Ogawa, S., Masuo, K., Goto, N., Hiramatsu, Y., Tsuda, M., Kimura, Y., Matsumoto, Y., Kimura, Y., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315425 · Cited by 7

Three-dimensional genomic mapping of human pancreatic tissue reveals striking multifocality and genetic heterogeneity in precancerous lesionsPreprint

Braxton, A. M., Kiemen, A. L., Grahn, M. P., Forjaz, A., Babu, J. M., Zheng, L., Jiang, L., Cheng, H., Song, Q., Reichel, R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.27.525553 · Cited by 8

Endosomal Trafficking Bypassed by the RAB5B‐CD109 Interplay Promotes Axonogenesis in KRAS ‐Mutant Pancreatic Cancer

Zhang, D., Luo, Y., Lin, Y., Fang, Z., Zheng, H., An, M., Xie, Q., Wu, Z. K., Yu, C., Yang, J., et al. (2024) · Advanced Science · doi:10.1002/advs.202405092 · Cited by 9

Depicting the cellular complexity of pancreatic adenocarcinoma by Imaging Mass Cytometry: focus on cancer-associated fibroblasts

Erreni, M., Fumagalli, M. R., D’Anna, R., Sollai, M., Bozzarelli, S., Nappo, G., Zanini, D., Parente, R., Garlanda, C., Rimassa, L., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1472433 · Cited by 7

The supporting role of Schwann cells in perineural invasion of pancreatic ductal adenocarcinoma

He, Y., Chen, Z., Yang, L., Qiao, S., Su, Z., Ding, F., Ding, F., Xin, F., Xiang, S., Lü, A., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1540027 · Cited by 9

SP1‐Mediated Glycolytic Reprogramming Promotes Tumorigenesis and Progression in Pancreatic Cancer

Hang, H., Yu, M., Zhu, L., Tang, N., Fu, X., Cai, Z., Yan, M., Chen, Y., Yang, L., Wu, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202510071 · Cited by 7

Tumor microenvironment subtyping in pancreatic ductal adenocarcinoma: New avenues for personalized therapeutic strategies

Srinivasan, D., Gout, J., Kleger, A., & Roger, É. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115697 · Cited by 7

Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma

Than, M. T., Dequiedt, L., Sor, R., Nair, S., Markosyan, N., Furth, E. E., Yang, C., Ray-Fofana, C., Menard, M. J., Quintana, E., et al. (2026) · Science · doi:10.1126/science.aec7929 · Cited by 9

Chronic jetlag accelerates pancreatic neoplasia in conditional Kras -mutant mice

Schwartz, P. B., Walcheck, M. T., Nukaya, M., Pavelec, D. M., Matkowskyj, K. A., & Ronnekleiv‐Kelly, S. M. (2023) · Chronobiology International · doi:10.1080/07420528.2023.2186122 · Cited by 7

Relationship between pancreatic intraepithelial neoplasias, pancreatic ductal adenocarcinomas, and single nucleotide polymorphisms in autopsied elderly patients

Matsuda, Y., Tanaka, M., Sawabe, M., Mori, S., Muramatsu, M., Mieno, M., Furukawa, T., & Arai, T. (2017) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22479 · Cited by 7

Endoscopic Ultrasonography with Fine-needle Aspiration

Haghighi, M., Packey, C. D., & Gonda, T. A. (2017) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2017.06.003 · Cited by 8

Identification of potential plasma protein biomarkers for feline pancreatic carcinoma by liquid chromatography tandem mass spectrometry

Nabeta, R., Katselis, G. S., Chumala, P., Dickinson, R., Fernandez, N. J., & Meachem, M. D. (2022) · Veterinary and Comparative Oncology · doi:10.1111/vco.12826 · Cited by 7

Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer

Chen, H., Yu, Y., Zhou, L., Chen, J., Li, Z., & Tan, X. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1049454 · Cited by 7

The inhibition of pancreatic cancer progression by K-Ras-overexpressing mesenchymal stem cell-derived secretomes

Huo, Q., Li, K., Sun, X., Zhuang, A., Minami, K., Tamari, K., Ogawa, K., Fishel, M. L., Li, B., & Yokota, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-41835-6 · Cited by 7

AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor

Ingle, K., LaComb, J. F., Graves, L. M., Baines, A. T., & Bialkowska, A. B. (2023) · PLoS ONE · doi:10.1371/journal.pone.0294065 · Cited by 7

Cytopathological Analysis of Cyst Fluid Enhances Diagnostic Accuracy of Mucinous Pancreatic Cystic Neoplasms

Utomo, W. K., Braat, H., Bruno, M. J., van Eijck, C. H. J., Koerkamp, B. G., Krak, N. C., van de Vreede, A., Fuhler, G. M., Peppelenbosch, M. P., & Biermann, K. (2015) · Medicine · doi:10.1097/md.0000000000000988 · Cited by 7

Transmissible gastroenteritis virus infection decreases arginine uptake by downregulating CAT-1 expression

Xia, L., Dai, L., & Yang, Q. (2018) · Veterinary Research · doi:10.1186/s13567-018-0591-1 · Cited by 7

Biology, pathophysiology, and epidemiology of pancreatic cancer

Dariya, B., Alam, A., & Nagaraju, G. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819457-7.00001-3 · Cited by 7

Genetic Alterations Associated With Progression From Pancreatic Intraepithelial Neoplasia to Invasive Pancreatic Tumor

Murphy, S. J., Hart, S. N., Lima, J. F., Kipp, B. R., Klebig, M. L., Winters, J. L., Szabo, C., Zhang, L., Eckloff, B. W., Petersen, G. M., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.049 · Cited by 199

Molecular genetics of pancreatic intraepithelial neoplasia

Feldmann, G., Beaty, R., Hruban, R. H., & Maitra, A. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1166-5 · Cited by 269

Precursor Lesions of Pancreatic Cancer

Yonezawa, S., Higashi, M., Yamada, N., & Goto, M. (2008) · Gut and Liver · doi:10.5009/gnl.2008.2.3.137 · Cited by 91

KRAS2 Mutations in Human Pancreatic Acinar-Ductal Metaplastic Lesions Are Limited to Those with PanIN: Implications for the Human Pancreatic Cancer Cell of Origin

Shi, C., Hong, S., Lim, P., Kamiyama, H., Khan, M. A., Anders, R. A., Goggins, M., Hruban, R. H., & Eshleman, J. R. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0206 · Cited by 109

Mutational spectrum of intraepithelial neoplasia in pancreatic heterotopia

Ma, C., Gocke, C. D., Hruban, R. H., & Belchis, D. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.09.023 · Cited by 19